MedTrace Logo

IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry

NCT03536897 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 168

Last updated 2024-11-27

No results posted yet for this study

Summary

This is a prospective, registry trial which will enroll women aged 65 and above with early stage, low risk breast cancer who will be treated with partial mastectomy and intraoperative radiation therapy (IORT). The primary aim is to determine the 5-year risk of in-breast tumor recurrence. Secondary aims include identification of acute- and late-toxicity, cosmetic result, disease-free survival and overall survival.

Conditions

Interventions

RADIATION

IORT

Intraoperative radiation therapy with INTRABEAM system to a dose of 20 Gy

Sponsors & Collaborators

  • Mount Carmel Health System

    lead OTHER

Principal Investigators

  • Malolan Rajagopalan, MD · Mount Carmel Health System

Eligibility

Min Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-27
Primary Completion
2028-02-27
Completion
2028-02-27

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03536897 on ClinicalTrials.gov